Latest news
Wet Age-Related Macular Degeneration Updates From ASRS 2026 - MedscapeMedscape · Fri, 07 Aug 2026 01:30:00 GMTWet AMD Drug Secures First FDA-Approved Bevacizumab Status - Streetwise ReportsStreetwise Reports · Fri, 31 Jul 2026 10:37:41 GMTCHMP Backs Roche’s Susvimo for Wet AMD, European Commission Decision Pending - Eyewire+Eyewire+ · Tue, 28 Jul 2026 18:13:12 GMTFDA Approves Lytenava Eye Injection for Wet Age-Related Macular Degeneration - WebMDWebMD · Mon, 27 Jul 2026 07:00:00 GMTOn 4th try, Outlook scores FDA nod for reformulated version of Roche's Avastin for AMD - Fierce PharmaFierce Pharma · Mon, 27 Jul 2026 07:00:00 GMTOTLK Stock Jumps Overnight After FDA Approval Of Wet AMD Drug — Analysts See Nearly 300% Upside - TradingViewTradingView · Sun, 26 Jul 2026 07:00:00 GMT